Only one big loser this week, and it was TEK:Tekcapital dropping 6% and reversing most of last week's 9% climb.
TAP:Taptica seems to be recovering slowly, and gained 5% this week but is still 36% down in the trading account.
TLOU:Tlou Energy had another great recovery week, climbing 12% after a 7% rise last week. Hopefully this means news is coming. This one is still 36% down and losing £988 so it would do the power of good for it to climb steadily.
CAML:Central Asia Metals had a brilliant week, climbing 13% and going to 27% profit of £1,507. I won't be top slicing any this time around - I'm holding for the huge dividends and I think the price could easily double for my best-run company.
Share of the Week is MTFB:Motif Bio which climbed 7% last week and the week before, but this week climbed 26% to go from a 6% loss to a 20% potential profit of £678. Clearly this is in anticipation of the FDA decision on iclaprim. Most folk seem optimistic of success. I hope so after the problems I've had with other junior pharmas!
Slowly slowly catchy monkey.
Here's the new performance chart showing difference between value and cost over the last 12 months
A nice upward trend line
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £42.91 | -£3.75 | |
| Portfolio cost | £56,971.94 | +£0 | |
| Portfolio sell value (bid price - commission) | £60,421.50 | (6.1%) | +£1,791.21 |
| Potential profits | £12,551.00 | +£1,184.07 | |
| Yr 4 Dividends | £60.50 | +£0 | |
| Yr 4 Profit from sales | £814.53 | +£0 | |
| Yr 4 Average monthly cash profit | £160.62 | (3.4%) | -£8.04 |
| Total Dividends | £1,298.83 | +£0 | |
| Total Profit from sales | £19,511.65 | +£0 | |
| Average monthly cash profit | £499.70 | (10.5%) | -£2.90 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash dropped from monthly fee, but £1,184 increased potential profits was great, with OPTI:Optibiotix and MTFB:Motif Bio contributing a similar amount. £600 was wiped off paper losses too, split mostly between MTFB:Motif Bio and TLOU:Tlou Energy.
Still a bit perilous.
Debut for the performance chart and it's going in the right direction
The SIPP looks like this after week 163
| Weekly Change | |||
| Cash | £122.84 | -£16.08 | |
| Portfolio cost | £37,825.18 | +£0 | |
| Portfolio sell value (bid price - commission) | £42,489.13 | (9.8%) | +£1,081.43 |
| Potential profits | £8,730.41 | +£1,056.76 | |
| Yr 4 Dividends | £0 | +£0 | |
| Yr 4 Interest | £0.04 | +£0.03 | |
| Yr 4 Profit from sales | £0 | +£0 | |
| Yr 4 Average monthly cash profit | -£19.29 | (-0.6%) | -£8.40 |
| Total Dividends | £1,342.25 | +£0 | |
| Total Interest | £0.07 | +£0.03 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £307.69 | (9.8%) | -£2.95 |
| (Sold stocks profit + Dividends - Fees / Months) |
Monthly fees have gone up now the portfolio is bigger. This is hammering the average monthly performance for year 4 until I make a sale. Long term average is still below target too so I need SBTX:SkinBioTherapeutics to spike so I can do some trading with them. Meanwhile potential profits are up over £1,000 thanks to OPTI:Optibiotix and CAML:Central Asia Metals, with a tiny amount of reduced loss thrown in for good measure.
Excellent looking gap forming.
Similar steepness of trend line to the ISA and share accounts.
The trading account looks like this after week 129
| Weekly Change | |||
| Cash | £18.80 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,418.41 | (-38.9%) | +£54.09 |
| Potential profits | £0 | +£0 | |
| Year 3 Dividends | £17.33 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £33.69 | (17.4%) | -£1.41 |
| Dividends | £18.48 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£1.54 | (-0.8%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Best week for a while mostly thanks to CAML:Central Asia Metals, which climbed 10% in this account and is now only £28 (6%) down. I may get to sell them soon and see if I can do a better job of my next trading attempt. Any profit will be removed from the account as I attempt to draw down the original injection
I do believe it's turning round!
Not enough of a turnaround to affect the dismal performance chart.
That's it for week 2 of 2019 and we're still gaining each week of the year. Let's see how many weeks we can go before suffering the first loss.
No comments:
Post a Comment